Health2 months ago
Novel Blood Cancer Treatment Effective In Three-Fourths Of Trial Patients | The Optimist Daily
According to new findings from an ongoing Phase 1/2 clinical research trial, a novel investigational immunotherapy resulted in successful response rates for 73 percent of patients...
